Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-09-05 19:53 Tx date 2024-09-03 |
$AVCR
Avricore Health Inc. |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
2,575,000 | |
Filed 2024-02-01 16:14 Tx date 2024-01-24 |
$AVCR
Avricore Health Inc. |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,500
+140,000 vol $0.075 each |
1,490,000 | |
Filed 2024-02-01 16:08 Tx date 2024-01-24 |
$AVCR
Avricore Health Inc. |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-10,500
-140,000 vol $0.075 each |
1,975,000 | |
Filed 2023-05-16 16:31 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
2,115,000 | |
Filed 2022-09-20 16:51 Tx date 2022-01-28 |
$AVCR
Avricore Health Inc. |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-350,000 vol |
0 | |
Filed 2021-11-18 16:26 Tx date 2021-11-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$37,500
+250,000 vol $0.15 each |
1,350,000 | |
Filed 2021-11-18 16:20 Tx date 2021-11-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-37,500
-250,000 vol $0.15 each |
350,000 | |
Filed 2021-04-19 22:14 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
1,115,000 | |
Filed 2021-04-19 21:21 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
1,115,000 | |
Filed 2021-04-19 21:21 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
||
Filed 2021-03-17 14:38 Tx date 2021-02-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+425,000 vol |
||
Filed 2021-02-18 02:34 Tx date 2021-02-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+425,000 vol |
||
Filed 2021-02-18 02:34 Tx date 2021-02-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+425,000 vol |
1,215,000 | |
Filed 2021-02-11 00:59 Tx date 2021-02-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+350,000 vol |
600,000 | |
Filed 2021-02-11 00:55 Tx date 2021-02-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$35,000
+350,000 vol $0.10 each |
1,100,000 | |
Filed 2021-01-11 21:25 Tx date 2020-12-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
790,000 | |
Filed 2021-01-11 21:06 Tx date 2020-12-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
||
Filed 2020-11-23 00:45 Tx date 2020-11-20 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+250,000 vol |
250,000 | |
Filed 2020-11-23 00:43 Tx date 2019-10-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-23 00:40 Tx date 2020-11-20 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+250,000 vol $0.10 each |
750,000 | |
Filed 2020-07-10 21:01 Tx date 2020-07-10 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,500
+500,000 vol $0.025 each |
500,000 | |
Filed 2020-07-10 21:00 Tx date 2019-10-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-01 23:14 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
290,000 | |
Filed 2019-11-01 23:08 Tx date 2019-10-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
140,000 |